Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism

Movement Disorders

Volumn 28, Issue 9, 2013, Pages 1212-1214

  Pita Lobo, Patrícia ^a,b   Coelho, Miguel ^a,b   Mestre, Tiago A ^a,b   Rosa, Mário M ^a,b,c   Ferreira, Joaquim J ^a,b,c  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b Neurological Clinical Research Unit   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

2 BETACARBOMETOXY 3BETA (4 IODOPHENYL) N (3 FLUOROPROPYL)NORTROPANE I 123; LEVODOPA; TRACER; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRADYKINESIA; BRAIN HEMORRHAGE; CASE REPORT; CHOREA; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; DYSKINESIA; DYSTONIA; GAIT; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; POSTTRAUMATIC PARKINSONISM; PRIORITY JOURNAL; RIGIDITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRAUMATIC BRAIN INJURY; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; ANTIPARKINSON AGENTS; CRANIOCEREBRAL TRAUMA; DYSKINESIA, DRUG-INDUCED; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 84883550892     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25556     Document Type: Article

References (10)

1. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117(Pt 4):859-876.
2. Krauss JK, Trankle R, Kopp KH. Post-traumatic movement disorders in survivors of severe head injury. Neurology 1996;47:1488-1492.
3. Samie MR, Selhorst JB, Koller WC. Post-traumatic midbrain tremors. Neurology 1990;40:62-66.
4. Jenner P. Preventing and controlling dyskinesia in Parkinson's disease-a view of current knowledge and future opportunities. Mov Disord 2008;23(Suppl 3):S585-S598.
5. Papa SM, Engber TM, Kask AM, Chase TN. Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration. Brain Res 1994;662(1-2):69-74.
6. Ruzicka E, Urgosik D, Jech R, et al. Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion. Mov Disord 2005;20:759-762.
7. Nutt JG, Holford NH. The response to levodopa in Parkinson's disease: imposing pharmacological law and order. Ann Neurol 1996;39:561-573.
8. Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Mov Disord 2000;15:459-466.
9. Stocchi F, Rascol O, Kieburtz K, et al. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol 2010;68:18-27.
10. Lim SY, Fox SH, Lang AE. Overview of the extranigral aspects of Parkinson disease. Arch Neurol 2009;66:167-172.